⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Bain Capital and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Bain Capital
↗Boston, USA
Bain Capital is a leading global private investment firm based in Boston, Massachusetts, with approximately $185 billion in assets under management. Founded in 1984 by partners from the consulting firm Bain & Company, the firm operates across a diverse range of asset classes, including private equity, venture capital, credit, public equity, impact investing, life sciences, real estate, and tech opportunities.
The firm is well-known for its value-added investment approach, working closely with management teams to drive growth and strategic improvements. Bain Capital Life Sciences, a dedicated business unit, focuses specifically on biopharmaceutical, medical device, diagnostic, and life science tool companies, managing billions in capital to support innovation for patients with unmet medical needs.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals|Biotechnology|Medical Devices|CRO|CDMO
Sub-Industry:Private Equity / Life Sciences Investment
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$297.8M (Reported 2023)
Founded:1984
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Investment Firm)
Modalities:Small molecule, mAb, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:16
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Bain Capital Life Sciences, Bain Capital Specialty Finance
Key Partnerships:Portfolio companies include Nuvalent, Amylyx Pharmaceuticals, SpringWorks Therapeutics, and others.
COMPETITION
Position:Leader
Competitors:Blackstone Life Sciences, KKR, The Carlyle Group, TPG Capital
LEADERSHIP
Key Executives:
John P. Connaughton - Chair
David Gross - Managing Partner
Adam Koppel - Managing Director, Life Sciences
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Bain Capital. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.